Denali Therapeutics CEO and key executive team

Denali Therapeutics's Chief Executive Officer, Director is Ryan Watts. Denali Therapeutics's key executives include Ryan Watts and 24 others.
Ryan Watts

Ryan Watts

Chief Executive Officer, Director
Alexander Schuth

Alexander Schuth

COO and Head of Corporate Development
Carole Ho

Carole Ho

Chief Medical Officer
Steve Krognes

Steve Krognes

Chief Financial Officer
Cindy Dunkle

Cindy Dunkle

Chief People Officer
Dolo Diaz

Dolo Diaz

Vice President, Development Sciences
Joe Lewcock

Joe Lewcock

Chief Scientific Officer
Peter Chin

Peter Chin

Vice President, Late Clinical
Matt Troyer

Matt Troyer

Vice President, Early Clinical
Chris Walsh

Chris Walsh

Associate General Counsel
Erica Kratz

Erica Kratz

Vice President, Regulatory
Cynthia Wong

Cynthia Wong

Vice President, Portfolio and Program Management
Tyler Nielsen

Tyler Nielsen

Vice President, Corporate Finance
Anantha Sudhakar

Anantha Sudhakar

Vice President, CMC Small Molecule
Douglas Cole

Douglas Cole

Director
Tony Estrada

Tony Estrada

Vice President, Small Molecule Discovery
Guna Kannan

Guna Kannan

Vice President, Biotherapeutics
Robert Nelsen

Robert Nelsen

Director
Darren Hart

Darren Hart

Vice President, Development Operations
Vicki Sato

Vicki Sato

Director
Jay Flatley

Jay Flatley

Director
Kimberly Scearce-Levie

Kimberly Scearce-Levie

Vice President, Translational Sciences
Laura Hansen

Laura Hansen

Vice President, Investor Relations
Marc Tessier-Lavigne

Marc Tessier-Lavigne

Director & Scientific Advisor
Dana Andersen

Dana Andersen

Chief Technical and Manufacturing Officer
Last updated: